Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
09/2005
09/08/2005DE10361813A1 Using hematopoietic growth factors for structural regeneration of tissue, useful e.g. for treating liver damage and wounds
09/08/2005DE102004010223A1 Using celandine, or its extracts, for treatment of halitosis and its causes, improves protein digestion and inhibits formation of volatile sulfur and nitrogen compounds
09/08/2005DE102004007966A1 Topische Zusammensetzung, enthaltend mindestens ein Aryloxim und Bisabolol Topical composition comprising at least one aryl oxime and bisabolol
09/07/2005EP1571216A2 Phosphodiesterase 8A
09/07/2005EP1571147A2 Pyrazole analogs acting on cannabinoid receptors
09/07/2005EP1571146A1 Nitrogen-containing heterocyclic compounds and medicinal use thereof
09/07/2005EP1571142A1 Novel anti-inflammatory and analgesic heterocyclic amidines that inhibit nitrogen oxide (NO) production
09/07/2005EP1571141A2 Naaladase inhibitors useful as pharmaceutical compounds and compositions
09/07/2005EP1570861A2 Pharmaceutical compositions based on anticholinergically effective compounds and beta-mimetics
09/07/2005EP1570860A1 Antagonist and agonist binding to strong binding site of chemokine receptor
09/07/2005EP1570854A1 Drug containing angiotensin convertase
09/07/2005EP1570847A1 Phosphodiesterase 10a inhibitors
09/07/2005EP1570845A1 Remedy
09/07/2005EP1570840A2 Topical composition comprising n-acetylaldosamines or n-acetylamino acids
09/07/2005EP1570839A1 Composition for preparation for external use on skin and method of using the same
09/07/2005EP1570752A1 Verwendung von ungesättigten Fettsäuren zur Verringerung des Appetits oder der Essensaufnahme
09/07/2005EP1570270A2 Therapeutic bioconjugates
09/07/2005EP1569930A1 Indol derivatives and their use as 5-ht ligands
09/07/2005EP1569900A2 Substituted 3-carbonyl-1-yl acetic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1)
09/07/2005EP1569899A2 SUBSTITUTED 3-ALKYL AND 3-ARYLALKYL i 1H /i -INDOL-1-YL ACETIC ACID DERIVATIVES AS INHIBITORS OF PLASMINOGEN ACTIVATOR INHIBITOR-1 (PAI-1)
09/07/2005EP1569723A2 Nucleotide based medicament and method of use for treatment of conditions in humans
09/07/2005EP1569689A2 Combination il2/anti-her2-antibody therapy for cancers characterized by overexpression of the her2 receptor protein
09/07/2005EP1569665A2 Composition and method for mammary disinfection during winter conditions
09/07/2005EP1569658A2 Treatment of ebv and khsv infection and associated abnormal cellular proliferation
09/07/2005EP1569652A2 N sp 4 /sp-acylcytosine nucleosides for treatment of viral iinfections
09/07/2005EP1569640A2 Combinations of peroxisome proliferator-activated receptor-alpha agonists and cyclooxygenase-2 selective inhibitors and therapeutic uses therefor
09/07/2005EP1569630A1 Methods for preventing phototoxic damage during photodynamic therapy
09/07/2005EP1569596A1 A method for preparing a medical solution for the manufacture of a medicament for peritoneal dialysis
09/07/2005EP1495023B1 Novel 1,2,3-substituted indolizine derivatives, inhibitors of fgfs, method for making same and pharmaceutical compositions containing same
09/07/2005EP1458717B1 Aroyl pyridinones
09/07/2005EP1401839B1 Antidepressant (sssri) azaheterocyclymethyl derivatives of 7,8-dihydro-3h-t,9-dioxa-1,3-diazacyclopenta [a] naphthalene
09/07/2005EP1399434B1 Novel indole derivatives
09/07/2005EP1377589B1 Oxazolyl-pyrazole derivatives as kinase inhibitors
09/07/2005EP1366039B1 Piperazinylcarbonylquinolines and -isoquinolines
09/07/2005EP1349850B1 Sodium channel modulators derived from 2-piperidylimidazoles
09/07/2005EP1333824B1 Treatment of sexual dysfunction with bombesin receptor antagonists
09/07/2005EP1328519B1 Orally active salts with tyrosine kinase activity
09/07/2005EP1299430B1 Process for preparing benzoxazin-4-one polymer conjugates
09/07/2005EP1280801B1 Hydantoin-containing glucokinase activators
09/07/2005EP1254133B9 Indol-3-yl derivatives and their use as integrin inhibitors
09/07/2005EP1192132B1 Serine protease inhibitors
09/07/2005EP1188747B1 Phenoxypropylamine compounds
09/07/2005EP1151109B1 Fucosyl transferase gene
09/07/2005EP1140026B1 Biodegradble polymer encapsulated serotonin receptor antagonist and method for preparing the same
09/07/2005EP1037634B1 Oral administration form comprising a proton pump inhibitor (e.g.pantoprazole)
09/07/2005EP1023308B1 Inhibitors of nucleoside metabolism
09/07/2005EP1013278B1 The extract of pine needle and the use thereof
09/07/2005EP0973532B1 Anti-proliferative preparations
09/07/2005EP0917537B1 Novel parathyroid hormone-related peptide analogs
09/07/2005CN1665931A Self-coalescing or self-aggregating proteins derived from a membrane translocating sequence
09/07/2005CN1665929A Circular dumbbell decoy oligodeoxynucleotides (CDODN) containing DNA bindings sites of transcription
09/07/2005CN1665831A Novel compounds, compositions as carriers for steroid/nonsteroid anti-inflammatory; antienoplastic and antiviral active molecules
09/07/2005CN1665822A 1-thia-3-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
09/07/2005CN1665821A 1-oxa-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
09/07/2005CN1665818A N-aryl diazaspiracyclic compounds and methods of preparation and use thereof
09/07/2005CN1665815A Novel tetracyclo-aryl-carbonyl indoles used as therapeutical agents with 5-hydroxy-tryptamine receptor affinity, their preparation process and pharmaceutical compounds containing same
09/07/2005CN1665810A Inhibitors of JAK and CDK2 protein kinases
09/07/2005CN1665809A Azaindoles
09/07/2005CN1665807A Novel physiolgically active substances
09/07/2005CN1665806A Medicine compound
09/07/2005CN1665804A 4, 4-disubstituted piperidine derivatives having CCR3 antagonism
09/07/2005CN1665803A Novel crystal forms of ondansetron, processes for their preparation, pharmaceutical, compositions containing the novel forms and methods for treating nausea using them
09/07/2005CN1665800A Novel thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions
09/07/2005CN1665798A Refreshment capable of stimulating movement of digestive tract
09/07/2005CN1665791A Quinazoline derivatives
09/07/2005CN1665789A Diaminopyrimidinecarboxa mide derivative
09/07/2005CN1665787A Process for the preparation of 7-substituted-3-quinoline and 3-quinol-4-one carbonitriles
09/07/2005CN1665786A Secondary amino anilinic piperidines as MCH1 antagonists and uses thereof
09/07/2005CN1665785A 2-cyano-4-fluoropyrrolidine derivative or its salt
09/07/2005CN1665780A Tricyclic steroid hormone nuclear receptor modulators
09/07/2005CN1665774A Cinnamide derivatives
09/07/2005CN1665566A Methods and compositions for the treatment of diabetes, the reduction of body fat, improvement of insulin sensitivity, reduction of hyperglycemia, and reduction of hypercholesterolemia with chromium c
09/07/2005CN1665546A Medicinal formulation in particular for treating herniated invertebral discs
09/07/2005CN1665541A Liquid formulations with a high concentration of human growth hormone (hgh) comprising glycine
09/07/2005CN1665540A Liquid formulations with a high concentration of human growth hormone (hgh) comprising glycine
09/07/2005CN1665539A Pharmaceutical compositions containing anticholinergics and EGFR kinase inhibitors
09/07/2005CN1665538A Phamaceutical combination of a thromboxane A2 receptor antagonist and a COX-2 inhibitor
09/07/2005CN1665537A Use of CETP inhibitors and optionally HMG COA reductable inhibitors and/or antihypertensive agents
09/07/2005CN1665534A Novel tissue factor targeted thrombomodulin fusion proteins as anticoagulants
09/07/2005CN1665533A Use of heat shock proteins to enhance efficacy of antibody therapeutics
09/07/2005CN1665526A Novel tissue factor targeted thrombomodulin fusion proteins as anticoagulants
09/07/2005CN1665524A Use of alanyl-aminopeptidase inhibitors and pharmaceutical compositions containing said inhibitors
09/07/2005CN1665521A Purified amylase inhibitor and novel process for obtaining the same
09/07/2005CN1665519A Carbon dioxide external preparation and material for formation of carbon dioxide external preparation
09/07/2005CN1665513A 1, 3-diaza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
09/07/2005CN1665512A Use of vasopeptidase inhibitors in the treatment of metabolic diseases, nephropathy and advanced glycation end-product associated diseases
09/07/2005CN1665510A Cyclothiocarbamative derivatives as PR modulators and use thereof for treatment of skin disorders
09/07/2005CN1665509A Synergistic interaction of abacavir and alovudine
09/07/2005CN1665503A Utilization of heteroarene carboxamide as dopamine-D3 ligands for the treatment of cns diseases
09/07/2005CN1665499A Drug composition for prevention or inhibition of advance of diabetic complication
09/07/2005CN1665498A Drug composition for blood sugar control
09/07/2005CN1665491A Microcapsules for the delayed, controlled release of perindopril
09/07/2005CN1665488A Direct cellular energy delivery system
09/07/2005CN1663607A Antisenescence medicine
09/07/2005CN1663595A Tendon-extending bone-penetrating spray of and its preparing method
09/07/2005CN1217956C Soluble single-chain T-cell receptor proteins
09/07/2005CN1217952C Compound
09/07/2005CN1217943C New use and novel N-azabicyclo-amide derivatives
09/07/2005CN1217938C Bis-arylsulfones
09/07/2005CN1217936C Heterocyclic compounds having sulfonamide
1 ... 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 ... 1564